Lubec G - Search Results

1

Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease.

Schneider C, Risser D, Kirchner L, Kitzmüller E, Cairns N, Prast H, Singewald N, Lubec G. Schneider C, et al. Among authors: lubec g. Neurosci Lett. 1997 Feb 7;222(3):183-6. doi: 10.1016/s0304-3940(97)13379-1. Neurosci Lett. 1997. PMID: 9148245

2

Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome.

Baran H, Cairns N, Lubec B, Lubec G. Baran H, et al. Among authors: lubec g, lubec b. Life Sci. 1996;58(21):1891-9. doi: 10.1016/0024-3205(96)00173-7. Life Sci. 1996. PMID: 8637415

3

Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease.

Seidl R, Beninati S, Cairns N, Singewald N, Risser D, Bavan H, Nemethova M, Lubec G. Seidl R, et al. Among authors: lubec g. Neurosci Lett. 1996 Mar 15;206(2-3):193-5. doi: 10.1016/s0304-3940(96)12451-4. Neurosci Lett. 1996. PMID: 8710184

4

Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease.

Hayn M, Kremser K, Singewald N, Cairns N, Nemethova M, Lubec B, Lubec G. Hayn M, et al. Among authors: lubec g, lubec b. Life Sci. 1996;59(7):537-44. doi: 10.1016/0024-3205(96)00334-7. Life Sci. 1996. PMID: 8761342

5

Endogenous opioids in frontal cortex of patients with Down syndrome.

Risser D, You ZB, Cairns N, Herrera-Marschitz M, Seidl R, Schneider C, Terenius L, Lubec G. Risser D, et al. Among authors: lubec g. Neurosci Lett. 1996 Jan 19;203(2):111-4. doi: 10.1016/0304-3940(95)12275-3. Neurosci Lett. 1996. PMID: 8834106

6

Decreased cyclin dependent kinase in brain of patients with Down syndrome.

Bernert G, Nemethova M, Herrera-Marschitz M, Cairns N, Lubec G. Bernert G, et al. Among authors: lubec g. Neurosci Lett. 1996 Sep 20;216(1):68-70. doi: 10.1016/0304-3940(96)12988-8. Neurosci Lett. 1996. PMID: 8892394

7

Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome.

Risser D, Lubec G, Cairns N, Herrera-Marschitz M. Risser D, et al. Among authors: lubec g. Life Sci. 1997;60(15):1231-7. doi: 10.1016/s0024-3205(97)00067-2. Life Sci. 1997. PMID: 9096240

8

Evidence against increased glycoxidation in patients with Alzheimer's disease.

Seidl R, Schuller E, Cairns N, Lubec G. Seidl R, et al. Among authors: lubec g. Neurosci Lett. 1997 Aug 22;232(1):49-52. doi: 10.1016/s0304-3940(97)00576-4. Neurosci Lett. 1997. PMID: 9292889

9

Evidence against increased oxidative DNA-damage in Down syndrome.

Seidl R, Greber S, Schuller E, Bernert G, Cairns N, Lubec G. Seidl R, et al. Among authors: lubec g. Neurosci Lett. 1997 Oct 17;235(3):137-40. doi: 10.1016/s0304-3940(97)00748-9. Neurosci Lett. 1997. PMID: 9406888

10

Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer's disease.

Hermon M, Cairns N, Egly JM, Fery A, Labudova O, Lubec G. Hermon M, et al. Among authors: lubec g. Neurosci Lett. 1998 Jul 17;251(1):45-8. doi: 10.1016/s0304-3940(98)00488-1. Neurosci Lett. 1998. PMID: 9714461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

708 results

Search Page

Filters